Home Depot Comparable Sales Catch Up to Lowes Potentially Lifting Stock Prospects Social Security Claiming Dilemma Weighing Early Benefits vs Survivors Payout for a 62YearOld Earning 20000 Billionaire Bill Ackman Boosts Amazon and Microsoft Holdings Cuts Alphabet Stake by 95 in First Quarter Jim Cramer Expresses Disappointment Over Toll Brothers Outlook South Korea and Netherlands Forge Broader Chip Alliance Beyond ASML Collaboration Dating App Authenticity Push Sparks Investor Interest as Startups Tackle Fake Profiles GIGM Q3 2025 Earnings Narrowing Loss Amid Quiet Quarter PRK Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery BrightView Holdings Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Earnings Shortfall SOBR Safe Inc SOBR Q3 2025 Earnings Loss Per Share Widens Amid Operational Challenges Adams Diversified Equity Fund ADX Rises 094 as Shares Approach Key Resistance Katapult Holdings Sheds Value Critical Support Level in Focus Skillz Inc SKLZ Surges 7 Breaking Down the Move and What Lies Ahead Quad Graphics QUAD Gains 18 as Stock Approaches Key Resistance Level Angel Studios Inc ANGX Surges 84 as Momentum Builds Toward Key Resistance Levels Political Scandal Over Film Funding Casts Doubt on Flvio Bolsonaros Presidential Campaign Monopar Therapeutics Q1 2026 Earnings Narrower Loss Surprises Market EverCommerce EVCM Gains 23 as Shares Approach Key Resistance Level Spring Valley Acquisition Corp III Unit SVACU Edges Higher as Trading Activity Remains Steady NVE Corporation NVEC Surges 45 Testing Key Resistance at 9608 Western Asset InflationLinked Income Fund WIA Holds Steady Near Support Inflation Hedge Dynamics in Focus Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals BiomX Inc PHGE Surges 105 Can the Rally Hold Above 078 Support American Woodmark AMWD Edges Higher Testing Key Resistance Levels Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29